These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. The chloramphenicol--hepatitis--aplastic anaemia syndrome. Hodgkinson R Med J Aust; 1973 May; 1(19):939-40. PubMed ID: 4715401 [No Abstract] [Full Text] [Related]
43. [Aplastic anemia following chloramphenicol]. Bar-Haim Y; Sadan N Harefuah; 1974 Feb; 86(4):197-9. PubMed ID: 4828260 [No Abstract] [Full Text] [Related]
44. Widespread ocular use of topical chloramphenicol: is there justifiable concern regarding idiosyncratic aplastic anaemia? McGhee CN; Anastas CN Br J Ophthalmol; 1996 Feb; 80(2):182-4. PubMed ID: 8814753 [TBL] [Abstract][Full Text] [Related]
45. Aplastic anemia associated with parenteral chloramphenicol: review of 10 cases, including the second case of possible increased risk with cimetidine. West BC; DeVault GA; Clement JC; Williams DM Rev Infect Dis; 1988; 10(5):1048-51. PubMed ID: 3055188 [TBL] [Abstract][Full Text] [Related]
46. Infectious hepatitis and aplastic anaemia. Hodgkinson R Lancet; 1971 May; 1(7707):1014. PubMed ID: 4102423 [No Abstract] [Full Text] [Related]
47. [Aplastic anemia caused by chloramphenicol]. Popadić M; Surbat G Med Arh; 1968; 22(5):33-7. PubMed ID: 5194588 [No Abstract] [Full Text] [Related]
48. Fatal aplastic anemia and chloramphenicol. Clarke WT Can Med Assoc J; 1967 Sep; 97(13):815. PubMed ID: 6050902 [No Abstract] [Full Text] [Related]
49. [Aplastic anemia following chloramphenicol treatment]. Armata J; Wyszkowski J; Zajaczkowski J; Cyklis R Pol Tyg Lek; 1971 Apr; 26(15):557-9. PubMed ID: 5578684 [No Abstract] [Full Text] [Related]
50. Aplastic anemia after parenteral chloramphenicol: warning renewed. Plaut ME; Best WR N Engl J Med; 1982 Jun; 306(24):1486. PubMed ID: 7078596 [No Abstract] [Full Text] [Related]
51. Aplastic anemia and chloramphenicol. Davidoff E Am J Ophthalmol; 1982 Aug; 94(2):268-9. PubMed ID: 7114158 [No Abstract] [Full Text] [Related]
52. [Blood dyscrasia in chloramphenicol therapy. A case of fatal aplastic anemia]. Mjos OD; Wraamann KN Tidsskr Nor Laegeforen; 1966 Sep; 86(18):1267-8. PubMed ID: 5915491 [No Abstract] [Full Text] [Related]
53. Ophthalmic chloramphenicol: a review of the literature. Field D; Martin D; Witchell L Accid Emerg Nurs; 1999 Jan; 7(1):13-7. PubMed ID: 10232108 [TBL] [Abstract][Full Text] [Related]
54. Phenylbutazone, oxyphenbutazone and aplastic anaemia. Böttiger LE Br Med J; 1977 Jul; 2(6081):265. PubMed ID: 884472 [No Abstract] [Full Text] [Related]
55. [Aplastic anemia after chloramphenicol therapy]. Ritland S; Frogn W Tidsskr Nor Laegeforen; 1970 Jul; 90(14):1484-6. PubMed ID: 5452276 [No Abstract] [Full Text] [Related]
57. Topical application of chloramphenicol eye ointment followed by fatal bone marrow aplasia. Brodsky E; Biger Y; Zeidan Z; Schneider M Isr J Med Sci; 1989 Jan; 25(1):54. PubMed ID: 2925363 [No Abstract] [Full Text] [Related]
58. Aplastic anemia following chloramphenicol therapy still happens! Lepow ML Pediatrics; 1986 Jun; 77(6):932-3. PubMed ID: 3714393 [No Abstract] [Full Text] [Related]
59. Sequential induction of aplastic anemia and acute leukemia by chloramphenicol. Abbas Z; Malik I; Khan A J Pak Med Assoc; 1993 Mar; 43(3):58-9. PubMed ID: 8326672 [No Abstract] [Full Text] [Related]
60. [Course and prognosis of aplastic anemia induced by chloramphenicol]. Manny N; Izak G Harefuah; 1975 Jun; 88(11):507-9. PubMed ID: 1158196 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]